Comparison of prognostic factors that affect the survival of patients with metachronous and synchronous metastases of renal cell carcinoma

Comparison of prognostic factors that affect the survival of patients with metachronous and synchronous metastases of renal cell carcinoma

Introduction. The differences in progression-free survival (PFS) and overall survival (OS) depending on the line of systemic therapy, the timing of the onset of metastases, and Heng prognostic groups in patients with metastatic renal cell carcinoma (mRCC) remain unclear. This leads to the search for...

Full description

Bibliographic Details
Main Authors: D. V. Semenov, R. V. Orlova, V. I. Shirokorad, S. V. Kostritsky, S. G. Grigoriev, Yu. S. Korneva
Format: Article
Language:Russian
Published: State Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian Federation 2022-10-01
Series:Vestnik Urologii
Subjects:
renal cell carcinoma
metastases
synchronous
metachronous
systemic therapy
Online Access:https://www.urovest.ru/jour/article/view/582

Similar Items

Similar Items